ArticleEuropean journal of neurology2024

Rates of John Cunningham virus seroconversion greatly reduced in natalizumab-treated patients during COVID-19-related lockdowns.

Chris Dwyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.